Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR3 | Q99500 | 1/20 | 0.42 |
| ▸ | CTSS | P25774 | 2/20 | 0.39 |
| ▸ | CTSK | P43235 | 2/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 8/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.39 |
| ▸ | SCN10A | Q9Y5Y9 | 4/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.36 |
| ▸ | METAP1 | P53582 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL23200628 | 0.80 | CTSS (0.41) | S1PR3CTSSCTSKMETAP1TRPA1 | |
| Lithium Ion SCHEMBL23200818 | 0.79 | CTSS (0.43) | S1PR3CTSSCTSKCYP3A4METAP1 | |
| SCHEMBL4172572 | 0.77 | S1PR3 (0.41) | S1PR3CTSSCTSKTRPM8SCN9A | |
| Lithium Ion SCHEMBL23200776 | 0.77 | S1PR3 (0.48) | S1PR3CTSSCTSKPTPN1 | |
| SCHEMBL14101230 | 0.76 | ALDH1A1 (0.38) | S1PR3CTSSCTSKTRPM8SCN9A | |
| Lithium Ion SCHEMBL11835380 | 0.74 | CTSK (0.63) | S1PR3CTSSCTSKSCN9A | |
| Lithium Ion SCHEMBL23200945 | 0.74 | S1PR3 (0.39) | S1PR3CTSSCTSKSCN9AAAK1 | |
| SCHEMBL17755289 | 0.74 | TRPM8 (0.40) | CTSSCTSKTRPM8SCN9AAAK1 | |
| SCHEMBL3196849 | 0.72 | CTSK (0.39) | S1PR3CTSSCTSKTRPM8SCN9A | |
| SCHEMBL2260258 | 0.71 | METAP1 (0.46) | AAK1METAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12173018-B2 | Penicillin-binding protein inhibitors | VenatoRx Pharmaceuticals, Inc. (US) | 2024-12-24 | — | — | US | disclosed |
| US-20210198288-A1 | PENICILLIN-BINDING PROTEIN INHIBITORS | VenatoRx Pharmaceuticals, Inc. | 2021-07-01 | — | — | US | disclosed |
| EP-3802551-A1 | PENICILLIN-BINDING PROTEIN INHIBITORS | Venatorx Pharmaceuticals, Inc. (US) | 2021-04-14 | — | — | EP | disclosed |
| CN-112469725-A | Penicillin binding protein inhibitors | 维纳拓尔斯制药公司 | 2021-03-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210198288-A1 | PENICILLIN-BINDING PROTEIN INHIBITORS | PEPD, BPGM, EBPL | S1PR3 4606/4885CTSS 1293/4885CTSK 2792/4885 |
| US-12173018-B2 | Penicillin-binding protein inhibitors | PEPD, BPGM, EBPL | S1PR3 4606/4885CTSS 1293/4885CTSK 2792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.